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Abstract
Background: Toxoplasmosis is a worldwide neglected tropical and sub-tropical infection caused by Toxoplasma gondii (T. gondii).
Most of the previous studies on the seroprevalence of T. gondii in Iran have been done at provincial level and on specific populations,
including pregnant females. Socioeconomic parameters are associated with the prevalence of this disease. In this study, the authors
evaluated the presence of anti-T. gondii antibodies and the related risk factors in Iranian adolescents.
Methods: This was a cross-sectional study on serum samples from the third Iranian national school-based survey (the CASPIAN III
study), which included 10- to 18-year-old students. Participants were selected by multistage sampling from 27 Iranian provinces. In
this study, serum samples of 882 adolescents from 16 provinces were randomly selected and examined for IgG and IgM antibodies
against T. gondiiby the Enzyme Linked Fluorescent Assay (ELFA). Demographic and socioeconomic factors related to T. gondii infection
were gathered using the global school-based health survey (GSHS) questionnaire.
Results: The overall T. gondii IgG and IgM seropositivity was 56.3% (95% CI: 53.4 to 59.2) and 3.7% (95%CI: 2.7 to 4.9), respectively. In mul-
tivariate logistic regression model, family size was statistically associated with seroprevalence of anti T. gondii IgG. Living in crowded
households (households with more than 4 people vs. households with less than 4 people) increased the risk of seropositivity of T.
gondii (OR: 1.40, 95% CI: 1.10 to 1.99).
Conclusions: The results of this study indicate that about 40% of Iranian adolescents have not had contact with the T. gondii, thus
the risk of congenital toxoplasmosis might be high in young females. Also, household size was the main factor associated with T.
gondii infection. Preventive strategies and health education in Iranian adolescents are recommended.
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1. Background
Toxoplasmosis is a worldwide neglected tropical and
sub-tropical infection caused by the intracellular proto-
zoan, called Toxoplasma gondii (1). Infection with T. gondii
does not cause important disease in immunologically nor-
mal hosts, however, it can be fatal in immunocompro-
mised individuals. Congenital toxoplasmosis is also an im-
portant health issue worldwide (2). The parasite completes
its life cycle in cat’s intestine and excreted infective oocytes
contaminate water and vegetables, and their ingestion can
infect humans. Eating tissue cysts in raw meat is another
way of human infection (3, 4).
Epidemiological evidence shows that one-third of the
world population has been in contact with T. gondii, how-
ever, the infection rate varies greatly by country, ranging
from 20% to 80% (5-7). Prevalence of T. gondii in different
regions is mainly dependent on culture, eating habits, and
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climate. For example, ingestion of undercooked meat is
routine in France, leading to a high seroprevalence in this
country (8, 9). In Latin America or sub-Saharan Africa, trop-
ical climate facilitates survival of oocytes in the environ-
ment, thus the prevalence is high (10, 11). Toxoplasmosis
is prevalent in Iran and various seroprevalence rates have
been reported from different regions of the country, which
might be due to the environmental, socio-economical, and
cultural differences in this country (12).
Although previous studies in Iran have reported sero-
prevalence of T. gondii in some specific groups, including
pregnant females and youth, most of them have been done
at provincial level (13-19) and studies at national level are
scare. This study was designed to evaluate the frequency of
anti-T. gondii antibodies and related risk factors in a repre-
sentative sample of Iranian adolescents.
2. Methods
2.1. Patients and Setting
The present study was designed as a cross sectional
study, which was run on representative data of the national
surveillance study, the CASPIAN III (2009 to 2010). The aims
and details of methods have been reported previously (20).
In this nationwide survey, 5528 students (10- to 18-year-
old) were selected by multistage random sampling. Over-
all, 27 out of 30 Iranian provinces took part in this study.
Sample size in each province was proportionate to the pop-
ulation of that province. In the first stage, schools were
randomly selected from lists provided by the informa-
tion bank of the Ministry of Education and thereafter stu-
dents were randomly enrolled. Stratified sampling was ap-
plied based on the level of school (elementary, secondary,
and high school) and the living area (urban vs. rural)
with equal gender ratios. One of the parents completed
a questionnaire containing demographic and socioeco-
nomic factors under supervision of one of the team mem-
bers and also signed a written informed consent for blood
sampling and use of data for research. Blood samples were
obtained from students and serum samples were stored at
-70°C for further use.
The researchers aimed to determine the seropreva-
lence of T. gondii in 3 age groups (10 to 12, 13 to 15, and 16
to 18) and both genders of Iranian adolescents; as the es-
timated prevalence was 40% (21), the researchers needed
a sample size of about 900 to obtain a 95% confidence in-
terval and 10% precision in the reported prevalence. A to-
tal of 900 residual serum samples of CASPIAN III from 16
provinces were selected randomly and were used in this
study along with their questionnaires. Only 882 samples
were available, because of depletion of samples in previous
studies.
2.2. Antibody Detection
IgG and IgM antibodies against T. gondii were screened
by the Enzyme Linked Fluorescent Assay (ELFA) method.
The test was performed on a fully automated Vitek im-
muno diagnostic assay system (VIDAS), as described by the
manufacturer. The anti-Toxo IgG and IgM (bioMérieux,
Marcy l’Etoile, France) immunoassays kit was used in this
study. IgG titers of≥ 4 IU/mL and IgM titers≥ 0.65 IU/mL
were considered as positive test results (22).
The researchers used data from CASPIAN III study
to record age, gender, residency (urban/rural), and so-
cioeconomic parameters of the participants. Number
of households, parents’ education, and parents’ occupa-
tion were included in the analysis, independently; how-
ever, variables such as having a private car, school type
(public/private), type of home (private/rented) and hav-
ing personal computer were summarized in a variable
named family socioeconomic status (SES). The method
and variables used for calculating family SES were initially
approved in the Progress International Reading Literacy
Study (PIRLS) for Iran (23). The parameters were given
scores and total scores were regarded as the SES score,
which was rated as low, moderate, and high. Related na-
tional ethical committees approved the CASPIAN III study
and Alborz University of Medical Sciences ethical commit-
tee accepted this survey.
2.3. Statistical Analysis
Seroprevalence of T. gondii is presented with 95% con-
fidence interval (CI). Seroprevalence of T. gondii across de-
mographic characteristics was compared using the Chi-
square test. Association of T. gondii seropositivity with de-
mographic characteristics was assessed using univariate
and multivariate logistic regression analysis. Results of lo-
gistic regression analysis was reported as odds ratio (OR)
and 95% confidence interval (CI). Significance level of P-
value was set at 0.05.
3. Results
Of the 900 students aged 10 to 18 years, who were se-
lected for the CASPIAN III study, samples from 882 (48.3% fe-
male) students were checked for anti-T. gondii antibodies.
The distribution of participants in different age groups,
residence areas, genders, and SES levels were nearly equal
to the CASPIAN III data.
Mean age of participants (14.82 ± 2.77 years) was not
different between males (14.78± 2.88) and females (14.86±
2.65). Overall, 61.52% of participants were from metropoli-
tan areas and 38.42% were from non-metropolitan regions.
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Distribution of students in school levels was 31.75% in pri-
mary, 41.72% in secondary, and 26.53% in high school. The
overall T. gondii IgG seropositivity was 56.3% (95%CI: 53.4 to
59.2). The T. gondii IgG serpositivity in males (57.96%) and fe-
males (54.78%) was not statistically significant. Table 1 dis-
plays the seropositivity of T. gondii IgG, according to stu-
dents’ demographic characteristics.
Table 1. Seroprevalence of Toxoplasma gondii in Iranian Adolescents According to
Demographic Characteristics: the CASPIAN III Studya
% 95 % CI
Entire study population 56.34 53.39 - 59.24
Age group, y
10 - 12 58.56 53.83 - 63.15
13 - 15 55.86 50.65 - 60.94
15 - 18 55.51 50.79 - 60.14
P value 0.65
Gender
Male 57.96 52.62 - 63.12
Female 54.78 50.03 - 59.46
P value 0.42
Residence area
Metropolitan 55.72 52.66 - 58.73
Non-metropolitan 57.1 51.52 - 62.5
P value 0.64
Number of households
4 52.96 47.9 - 57.96
> 4 58.51 54.95 - 61.99
P value 0.1
SES
Low 53.02 46.61 - 59.34
Mod 61.42 55.62 - 66.92
High 54.78 50.04 - 59.43
P value 0.11
Father education
Illiterate 58.28 51.24 - 65
Under diploma 56.72 51.22 - 62.07
Diploma and academic 55.56 50.32 - 60.67
P value 0.84
Mother education
Illiterate 54.47 48.59 - 60.23
Under diploma 59.38 54.68 - 63.92
Diploma and academic 50.37 41.7 - 59.01
P value 0.15
Mother occupation
Employed 43.86 30.29 - 58.41
Housewife 57.16 54.58 - 59.71
P value 0.07
Father occupation
Unemployed 58.82 46.17 - 70.41
Employed/office work 54.18 49.69 - 58.61
Self employed 58.43 52.16 - 64.43
P value 0.48
Abbreviation: SES, socioeconomic status.
a By Chi-Square test.
The overall T. gondii IgM seropositivity was 3.7% (95%CI:
2.7 to 4.9). The T. gondii IgM seropositivity in males (3.48%)
and females (3.83%) was not statistically different (P value:
0.81). Figures 1 and 2 show the seroprevalence of T. gondii
IgG and IgM, according to age groups. The seroprevalence
of T. gondii IgG and IgM was not statistically different across
age groups.
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Figure 1. Seroprevalence of Toxoplasma gondii IgG According to Age in Iranian Ado-
lescents: the CASPIAN III Study
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Figure 2. Seroprevalence of Toxoplasma gondii IgM by Age in Iranian Adolescents:
the CASPIAN III Study
Table 2 shows the association of demographic char-
acteristics and T. gondii IgG seroprevalence in univariate
and multivariate logistic regression analysis. In univari-
ate model, the SES of family was associated with seropreva-
lence of T. gondii. In multivariate model, number of house-
hold members was statistically associated with seropreva-
lence of T. gondii. Living in a crowded household (house-
holds with more than 4 people compared to households
with less than 4 people) increased the risk of seropositiv-
ity of T. gondii (OR: 1.40, 95% CI: 1.10 to 1.99).
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Table 2. The Association of Toxoplasma gondii Seropositivity with Independent Variables in Logistic Regression Analysis: the CASPIAN III Study
Crude Adjusted
OR (95 % CI) P Value OR (95 % CI) P Value
Age group, y
10 - 12 Reference - - -
13 - 15 0.88 (0.62 - 1.24) 0.47 0.86 (0.59 - 1.24) 0.42
15 - 18 0.86 (0.59 - 1.24) 0.41 0.77 (0.51 - 1.16) 0.22
Number of households
< 4 Reference - - -
> 4 1.26 (0.95 - 1.70) 0.09 1.40 (1.1 - 1.99) 0.04
Gender
Male Reference - - -
Female 0.87 (0.63- 1.22) 0.42 0.86 (0.64 - 1.14) 0.3
SES
Low Reference - - -
Moderate 1.41 (1.01 - 1.95) 0.03 1.34 (0.95 - 1.93) 0.07
High 1.07(0.75 - 1.53) 0.68 1.22 (0.85 - 1.22) 0.23
Residence area
Metropolitan Reference - - -
Non-metropolitan 1.05 (0.82 - 1.36) 0.64 1.01 (0.74 - 1.37) 0.94
Abbreviation: SES, socioeconomic status.
4. Discussion
This study revealed a seroprevalence of 56.3% and 3.7%
for IgG and IgM antibodies against T. gondii in Iranian ado-
lescent, respectively. As shown by Figure 1, seroprevalence
of T. gondii was not much different for participants of dif-
ferent ages (ranging from about 50% to 60%). This might
propose that the infection is acquired early and almost be-
fore the age of 10 in Iranians.
Studies have been performed to evaluate T. gondii in-
fection in pregnant females or females of the childbearing
age in some countries and different seroprevalence rates
were estimated. The reported seroprevalence of T. gondii in-
fection was 71% in France (8, 9). Prevalence of T. gondii anti-
bodies was 78% in Nigerian pregnant females (11), 22.5% in
the population of United States (24), 92.5% in Ghana (25),
43% in Austria (26), 22.1% in Slovakia (27), 30% in Spain (28),
24.6% in Turkey (29), and 59% in Argentina (30).
The current found an overall T. gondii seroprevalence
of 60% in the studied adolescents, which indicates that T.
gondii prevalence in Iran is not as much as the prevalence
in countries, such as France, Ghana, and Nigeria (8, 9, 25,
31-33).
In Iran, the prevalence rates of anti-toxoplasma were
highly variable. The current findings are consistent with
prior reports on toxoplasmosis in several provinces of Iran.
Previous studies reported that 71% and 55.7% of subjects in
Sari and the Caspian Sea area were infected with T. gondii,
respectively (18, 34).
This study investigated the household and individual-
level risk factors for toxoplasmosis. Results of the present
study show that only household size was associated with
toxoplasmosis. In fact, demographic factors such as age,
gender, residence area, parents’ education, father’s job,
and socioeconomic status were not associated with toxo-
plasmosis. The researchers found that children living in
crowded households (households with more than 4 peo-
ple) were more likely to have positive T. gondii test results
than those with a small household size (households with
less than 4 people); as the parasite is not transmitted by di-
rect human contact, the reason for this association is not
clear and it might be related to other risk factors, such as
food hygiene and nutritional habits, which were not as-
sessed in this study.
Several studies in Iran and other countries have as-
sessed the risk factors for toxoplasmosis; previous system-
atic review and meta-analysis studies in Iran, which were
conducted on risk factors of toxoplasmosis in pregnant fe-
males and general population show that the place of res-
idence and keeping pets were 2 significant risk factors of
toxoplasmosis (21, 35). In the general population, having
direct contact with cats, consumption of uncooked meat
and raw fruits or vegetables, low level of education, and
living in rural areas were the main risk factors of toxoplas-
mosis (21). This study, in line with the study of Gyang et
al. could not find any associations between age, gender,
place of residence, and parents’ occupation/educational
level with toxoplasmosis (36). In another study in Turkey,
the researchers did not find any relationship between T.
gondii prevalence and family size, level of education, and
socioeconomics of the family (37). The reason for these con-
troversies is not obvious; different target populations with
diverse cultures and different study designs with regard to
the included risk factors might stand for these discrepan-
cies.
Strengths and limitations: The data of the present
study was obtained from a representative nationwide sur-
4 Arch Pediatr Infect Dis. 2018; 6(1):e61640.
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vey on adolescents, which increases generalizability of
the findings. It was not possible to include all Iranian
provinces in this study, which may decrease generalizabil-
ity of findings. In addition, the researchers were not able to
assess probable risk factors of T. gondii infection, including
keeping a pet, consuming raw or undercooked meat and
unwashed vegetables and fruits.
Conclusion: The results of this study indicate that
about 40% of Iranian adolescent have not had contact with
the T. gondii, thus a considerable proportion of young fe-
males are at risk of congenital toxoplasmosis. Also, house-
hold size (living in a crowded family) was the main risk fac-
tor of T. gondii infection. Preventive strategies and health
education for Iranian adolescents are recommended.
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